Trademark: 79371135
Word
AXXINOVAR
Status Date
Tuesday, January 30, 2024
Registration Number
7292506
Registration Date
Tuesday, January 30, 2024
Filing Date
Monday, August 22, 2022
Published for Opposition
Tuesday, November 14, 2023
5 Medicinal and pharmaceutical preparations for use in the syndromic approach for treating pain, headache, fever, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory disease, obstetrical/gynecological conditions, cardiovascular disease, skin diseases, allergic reactions, musculo-skeletal and joint diseases, kidney and urological disorders, otolaryngological diseases, eye diseases, neurological system diseases, metabolic and endocrinological diseases, hematological diseases, malignant diseases, protozoal infections and conditions, sexually transmitted infections, HIV and other viral infections, nutritional disorders and poisoning; pharmaceutical preparations, namely, contraceptive preparations
35 Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; providing advertising, marketing and promotional services for the pharmaceutical and medical products of others
42 Scientific and medical research and development in the fields of medicines, diagnostic aids and radio-pharmaceuticals for the treatment of pain, headaches, fevers, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory conditions, obstetrical/gynecological conditions and contraception, cardiovascular conditions, skin diseases and allergic reactions, musculo-skeletal and joint conditions, kidney and urological disorders, otolaryngological diseases, eye conditions, neurological conditions, metabolic and endorcinological conditions, hematological conditions, trauma and injuries, malignant disease conditions, malaria, tuberculosis, leprosy, sexually transmitted infections, HIV and other viral infections and conditions, protozoa infections and conditions, poisoning; medical research laboratory services; providing medical and veterinary research information in relation to all of the above; providing medical and scientific research information in the field of pharmaceuticals
Jun 8, 2023
Sn Assigned For Sect 66a Appl From Ib
Jun 13, 2023
New Application Office Supplied Data Entered
Jun 13, 2023
Assigned To Examiner
Jun 16, 2023
Non-Final Action Written
Jun 17, 2023
Application Filing Receipt Mailed
Jun 17, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Jul 24, 2023
Refusal Processed By Mpu
Jul 24, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Aug 15, 2023
Refusal Processed By Ib
Oct 5, 2023
Teas Response To Office Action Received
Oct 5, 2023
Correspondence Received In Law Office
Oct 5, 2023
Teas/Email Correspondence Entered
Oct 6, 2023
Approved For Pub - Principal Register
Oct 25, 2023
Notification Of Possible Opposition Sent To Ib
Nov 14, 2023
Published For Opposition
Oct 25, 2023
Notification Of Notice Of Publication E-Mailed
Oct 25, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 13, 2023
Notification Processed By Ib
Nov 14, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 30, 2024
Registered-Principal Register
Apr 30, 2024
Final Disposition Notice Created, To Be Sent To Ib
Jan 30, 2024
Notice Of Registration Confirmation Emailed
Sep 8, 2024
Teas Change Of Correspondence Received
Sep 8, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 8, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 22, 2024
Final Decision Transaction Processed By Ib
May 1, 2024
Final Disposition Processed
May 1, 2024
Final Disposition Notice Sent To Ib
Trademark Alertz updated from USPTO on 2030-01-24
